• Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Home > Publishers > MP Advisors
Publisher
Filter

MP Advisors Report List

MP Advisors is a Consultancy firm with an exclusive focus on Pharmaceuticals / Biotechnology sectors in the US, Europe, India, Japan and Russia. It was operating earlier as an international affiliate of Mehta Partners LLC since 1996. Today it has a highly motivated, qualified team of PhD's, MBA's and Pharmacist who apply their domain knowledge to develop proprietary data bases, understand dynamic regulatory laws across geographies, track and analyze latest trends in drug development, clinical trials and specific diseases. MP Advisors has insightful information on more than 200 pharma and Biotech companies around the globe as well as publishes reports on Key Opinion Leaders (Physician’s view) assessment, therapy class review of several classes (e.g. Oral anticoagulants, Hepatitis C, Obesity, Novel Drug Delivery systems, Biosimilars etc.), India and Japan generic opportunities and Paragraph IV Opportunities.

New for 2017!
Filter
Title Search
1 - 25 of 30 Products Sort by Display
Japan Biosimilars - A start of Authorized Biosimilar Era?
Published by
MP Advisors
Product code
541442
Published
August 14, 2017
Content info
128 Pages
Price
USD 4000
Sample available
Prostate Cancer - Newer Antiandrogens & Emerging Therapies Targeting a "Watchful Waiting" and Resistance Population
Published by
MP Advisors
Product code
430711
Published
February 1, 2017
Content info
200 Pages
Price
USD 4500
Sample available
Pain Management - New Discoveries And Treatment Options In Abuse Deterrent Era
Published by
MP Advisors
Product code
368679
Published
September 1, 2016
Content info
135 Pages
Price
USD 3500
Sample available
Large Cap Pharma US & EU Outlook 2016: Maximizing Their Strength On Fewer Therapy Class, Personalized Medicine, Novel Target And Biosimilars For Future Growth
Published by
MP Advisors
Product code
355096
Published
March 17, 2016
Content info
97 Pages
Price
USD 2000
Sample available
India Pharma Outlook 2016: Milestones to Watch - Growth from Exports and Domestic Getting Better, Implementation of Policies under "Make-in-India", Overture of A New Ministry
Published by
MP Advisors
Product code
355095
Published
March 17, 2016
Content info
 
Price
USD 1500
Sample available
Japan Pharma Outlook 2016:  JP Giants leaning in for becoming a Speciality Global Pharma
Published by
MP Advisors
Product code
355094
Published
March 10, 2016
Content info
91 Pages
Price
USD 2500
Sample available
Rising Stars Outlook 2016: New Emergence of Potential Tx & Dx Options could transform the Current Landscape for Liver Diseases (NASH)
Published by
MP Advisors
Product code
355093
Published
February 1, 2016
Content info
56 Pages
Price
USD 2000
Sample available
*
Published by
MP Advisors
Product code
348143
Published
January 4, 2016
Content info
101 Pages
Price
USD 4000
Sample available
Non-Alcoholic SteatoHepatitis (NASH): An Analysis of Disease Prevalence, Drugs in development, Regulatory guidelines and Market opportunity in Various Geographies
Published by
MP Advisors
Product code
346132
Published
December 1, 2015
Content info
65 Pages
Price
USD 3500
Sample available
*
Published by
MP Advisors
Product code
341195
Published
October 1, 2015
Content info
70 Pages
Price
USD 3000
Sample available
*
Published by
MP Advisors
Product code
295955
Published
February 2, 2015
Content info
109 Pages
Price
USD 2000
Sample available
*
Published by
MP Advisors
Product code
295953
Published
January 27, 2015
Content info
153 Pages
Price
USD 2000
Sample available
Sri Lanka Pharma Market Outlook 2015: More beyond Importers & Distributors
Published by
MP Advisors
Product code
324901
Published
January 26, 2015
Content info
29 Pages
Price
USD 2000
Sample available
*
Published by
MP Advisors
Product code
296608
Published
January 26, 2015
Content info
63 Pages
Price
USD 2000
Sample available
Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success
Published by
MP Advisors
Product code
295956
Published
January 26, 2015
Content info
90 Pages
Price
USD 2000
Sample available
India Rising Stars Outlook 2015: Traditionally Innovation and drug discovery had taken a back seat in the Indian pharma industry with a few blips here and there
Published by
MP Advisors
Product code
324902
Published
January 21, 2015
Content info
22 pages
Price
USD 1000
Sample available
*
Published by
MP Advisors
Product code
323219
Published
January 21, 2015
Content info
82 Pages
Price
USD 3000
Sample available
*
Published by
MP Advisors
Product code
323218
Published
January 21, 2015
Content info
98 Pages
Price
USD 3000
Sample available
New Phase of Mab Biosimilar knocks the door Biosimilar Opportunities In Japan
Published by
MP Advisors
Product code
323076
Published
January 21, 2015
Content info
65 Pages
Price
USD 4000
Sample available
*
Published by
MP Advisors
Product code
323075
Published
January 21, 2015
Content info
62 Pages
Price
USD 2000
Sample available
*
Published by
MP Advisors
Product code
295954
Published
January 21, 2015
Content info
72 Pages
Price
USD 2000
Sample available
*
Published by
MP Advisors
Product code
324417
Published
January 13, 2015
Content info
65 Pages
Price
USD 3000
Sample available
Therapeutic Class Overview : Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and Emergence of Novel Mechanisms in the Management of Pain
Published by
MP Advisors
Product code
322979
Published
January 1, 2015
Content info
 
Price
USD 3000
Sample available
Newer Oral Anti Androgens - Expanding Role in the treatment Paradigm of Prostate Cancer
Published by
MP Advisors
Product code
296614
Published
February 25, 2014
Content info
44 Pages
Price
USD 2500
Sample available
Emergence Of Biogenerics Era In Japan: It's Time to Welcome antibody Biosimilars of Foreign Origins Soon!
Published by
MP Advisors
Product code
296613
Published
February 25, 2014
Content info
31 Pages
Price
USD 2500
Sample available